IAS 2009
The 5th IAS Conference on HIV Pathogenesis, Treatment, and Prevention took place in Cape Town in July 2009.
-
19-22 July 2009
-
Cape Town, South Africa
ART for mothers leading to decline in child deaths, KwaZulu Natal study finds
Antiretrovirals and condoms will have more effect on HIV in South Africa than circumcision, model finds
Boosted darunavir monotherapy works well in two studies
Delays in starting treatment common in ART programmes
Sustained response to interferon improves fibrosis in HIV/HCV co-infected patients
Anal cancer in men with HIV much more common in post-HAART era: could HPV vaccination help?
Early tests of maraviroc as microbicide produce less activity than expected
Aciclovir reduces disease progression and death in people with HIV by nearly 20 per cent
Boosted and unboosted atazanavir maintain viral suppression equally well
Antiretroviral roll-out results in major TB decline in South African study
Cost of ART delivery in Malawi affordable within WHO-recommended health budget
`Test and treat` unlikely to halt Washington epidemic
Once-daily Kaletra as safe and effective as twice-daily dosing
Lopinavir/ritonavir cost-effective first-line after single-dose nevirapine in South Africa
High-risk HPV infection raises HIV risk at least fourfold: HPV vaccine study suggested
Resurgence of TB, diarrhoeal disease and malnutrition in Zimbabwe due to hyperinflation and economic collapse
Experimental integrase inhibitor GSK-572 looks good in early studies
-
22 July 2009